Phenyl-Med, Nandrolone Phenylpropionate, 150 mg/ml, 10 ml
Nandrolone Phenylpropionate 150 mg/ml by Bioniche Pharma is a fast-acting parenteral anabolic solution derived from the $19\text{-nortestosterone}$ steroid family. Formulated by Bioniche Pharma with a short phenylpropionate ester chain for rapid active absorption, Bioniche Pharma Nandrolone Phenylpropionate offers robust anabolic activity paired with moderate androgenic properties to drive cellular protein synthesis and enhance nitrogen conservation.
CLINICAL PHARMACOLOGY & MECHANISM OF ACTION
Nandrolone Phenylpropionate by Bioniche Pharma operates via direct interaction with intracellular nuclear androgen receptors in target tissues, shifting systemic nitrogen balance toward a positive state to accelerate skeletal muscle repair and tissue accretion. Due to its $19\text{-nor}$ chemical configuration, Bioniche Pharma Nandrolone Phenylpropionate demonstrates significantly reduced aromatization compared to native testosterone. However, it displays intrinsic affinity for progesterone receptors, requiring appropriate clinical oversight during therapy.
INDICATIONS & CLINICAL USE
- Anabolic support and tissue regeneration in individuals recovering from hypercatabolic states, major surgical trauma, or chronic debilitating conditions using Bioniche Pharma formulations.
- Adjunctive clinical management for refractory anemias and the preservation of bone mineral density under medical direction.
CONTRAINDICATIONS
- Male patients with diagnosed or suspected prostate carcinoma or male breast cancer.
- Pregnancy, planned pregnancy, and lactation due to high risks of female fetal virilization and structural developmental toxicity.
- Known hypersensitivity or allergic response to Nandrolone Phenylpropionate, carrier oil vehicles, or inactive compounding excipients in Bioniche Pharma injectables.
PRECAUTIONS & CLINICAL MONITORS
- Virilization Risk in Females: Female patients treated with Bioniche Pharma Nandrolone Phenylpropionate should be screened regularly for virilizing effects, such as vocal pitch alteration (dysphonia), hirsutism, acne, clitoromegaly, and menstrual cycle disruption. Immediate medical re-evaluation is warranted upon initial symptom detection.
- Cardiovascular & Lipid Monitoring: Exogenous $19\text{-nor}$ steroids can alter lipid panel values by lowering HDL and raising LDL cholesterol levels during Bioniche Pharma therapy. Clinical caution is advised for patients with existing coronary artery disease or past myocardial infarction, alongside periodic serum lipid testing.
- Systemic Observations: Routine patient oversight should monitor for gastrointestinal distress, skin color alterations, lower extremity swelling (peripheral edema), acne vulgaris, gynecomastia, or behavioral changes.
ADVERSE REACTIONS
- Endocrine & Reproductive: Reversible suppression of the endogenous hypothalamic-pituitary-gonadal (HPG) axis, progestin-mediated gynecomastia, and changes in serum prolactin levels linked to Bioniche Pharma Nandrolone Phenylpropionate administration.
- Dermatological & Androgenic: Elevated sebum production, acne vulgaris, oily skin, hair thinning, and libido shifts. Higher doses of Bioniche Pharma preparations increase the incidence of virilizing signs in female patients.
- Cardiovascular & Hematological: Mild sodium and water conservation leading to potential blood pressure elevations; routine complete blood count (CBC) testing is advised during treatment.
DOSAGE & ADMINISTRATION
Nandrolone Phenylpropionate by Bioniche Pharma is designed exclusively for deep intramuscular administration. Given the fast elimination rate of the phenylpropionate ester, Bioniche Pharma injections are typically divided into 2 to 3 doses per week:
- Adult Males: Standard therapeutic protocols for Bioniche Pharma Nandrolone Phenylpropionate generally total 300 mg to 600 mg weekly under medical direction.
- Adult Females: Where clinically indicated, therapeutic regimens for Bioniche Pharma Nandrolone Phenylpropionate are typically maintained at 50 mg to 100 mg per week, tailored to mitigate virilization risks.
STORAGE & HANDLING
Store Bioniche Pharma Nandrolone Phenylpropionate in a dry, cool location protected from direct light exposure and elevated ambient temperatures. Do not refrigerate or freeze. Keep strictly out of the reach and sight of children.